Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes.
Amy K MottlJohn B BuseFaramarz Ismail-BeigiRonald J SigalCarolyn F PedleyVasilios PapademetriouDebra L SimmonsLois KatzJosyf C MychaleckyjTimothy E CravenPublished in: Clinical journal of the American Society of Nephrology : CJASN (2018)
In people with type 2 diabetes at high risk for cardiovascular disease, intensive glycemic control may result in a long-term reduction in macroalbuminuria; however, intensive BP control and fenofibrates may increase the risk for adverse kidney events.